Author

Esther García-Planella 1

1 Hospital de la Santa Creu i Sant Pau

CLINICAL DIFFERENTIAL CHARACTERISTICS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) OF ONSET IN PEDIATRIC AGE COMPARED TO PATIENTS DIAGNOSED IN ADULTHOOD

Maria Chaparro Sanchez, Ana Garre, Elena Ricart, Valle García-Sánchez, Carlos Taxonera, Miriam Mañosa, Isabel Vera Mendoza, Miguel Mínguez, Federico Argüelles, Luisa de Castro, M Arroyo, Antonio López-Sanromán, Montserrat Rivero Tirado, Jordi Guardiola Capon, María Dolores Martín-Arranz, Belen Beltran, Jesús Barrio, Sabino

EFFICACY AND SAFETY OF THE SEQUENTIAL USE OF A SECOND AND THIRD ANTI-TNF DRUG IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

María José Casanova, Maria Chaparro Sanchez, Miguel Mínguez, Elena Ricart, Carlos Taxonera, Santiago García-López, Jordi Guardiola Capon, Antonio López-San Román, Eva Iglesias, Pilar Nos, Beatriz Sicilia, Maria Isabel Vera, Joaquin Hinojosa, Sabino Riestra, Eugeni Domenech Morral, Xavier Calvet Calvo, José Lázaro Pérez-Call

IMMUNOSUPPRESSIVE TREATMENT IS NOT A RISK FACTOR TO DEVELOP A WORSE SARS-COV-2 INFECTION IN ELDERLY IBD PATIENTS. AN OBSERVATIONAL, DESCRIPTIVE, COHORT STUDY

Margalida Calafat Sard, Carlos Gonzalez Muñoza, Marta Fortuny, Cristina Roig, Anna Calm, Antonio Mombiela, Fiorella Cañete, Federico Bertoletti, Miriam Mañosa Ciria, Jordi Gordillo, Esther García-Planella, Eugeni Domenech Morral

INTRAVENOUS CORTICOSTEROIDS IN MODERATE ACTIVE ULCERATIVE COLITIS NOT RESPONDING TO ORAL CORTICOSTEROIDS

Jordina Llaó, Juan Enrique Naves, Alexandra Ruiz Cerulla, Laura Marin, Miriam Mañosa Ciria, Lorena Rodríguez-Alonso, EDUARD CABRE, Esther García-Planella, Jordi Guardiola Capon, Eugeni Domenech Morral, Lorena Rodríguez-Alonso, Jordi Guardiola Capon

Is the switch to a second thiopurine a safe strategy in elderly patients with inflammatory bowel disease? A multicentre cohort study of the ENEIDA registry

Margalida Calafat Sard, Miriam Mañosa, Elena Ricart, Sandra Marín Pedrosa, Marta Calvo, Francisco Rodriguez-Moranta, Carlos Taxonera Samso, Pilar Nos Mateu, Francisco Mesonero, Mariló Martin-Arranz, Miguel Mínguez, Javier Gisbert, Santiago López, Ruth De Francisco Garcia, Fernando Gomollón Garcia, Xavier Calvet, Esther Garc

MANAGEMENT AND OUTCOME OF POSTOPERATIVE CROHN’S DISEASE IN THE ELDERLY AS COMPARED TO YOUNG ADULTS: DATA FROM ENEIDA REGISTRY

Miriam Mañosa Ciria, Elena Ricart, Pilar Nos Mateu, Margalida Calafat Sard, Eva Iglesias, Sabino Riestra Menéndez, Antonio López-Sanromán, Maribel Vera, Montserrat Rivero, Vicent Hernández Ramírez, Daniel Carpio López, Miguel Minguez Pérez, Jordi Guardiola Capon, Cristina Alba, Mº Dolores Martin-Arranz, Esther Rodríguez-Gonz

MANAGEMENT AND OUTCOME OF SEVERE ATTACKS OF ULCERATIVE COLITIS IN THE ERA OF BIOLOGICALS

Jordina Llaó, Juan Enrique Naves, Alexandra Ruiz Cerulla, Jordi Gordillo, Miriam Mañosa Ciria, EDUARD CABRE, Esther García-Planella, Jordi Guardiola Capon, Eugeni Domenech Morral, Jordi Guardiola Capon

OBSERVATIONAL STUDY ON THE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN AN ULCERATIVE COLITIS POPULATION COMPRISED BY BIO-NAÏVE PATIENTS AND PATIENTS WITH FAILURE OF ONE PREVIOUS ANTI-TNF (EVOLVE-IB STUDY)

Francisco Casellas, Cristina Rodriguez, Claudia Herrera de Guise, Javier Pérez Gisbert, Isabel Vera Mendoza, María Dolores Martín-Arranz, Sabino Riestra, Pilar Martínez-Montiel, Vanesa Royo, Patricia Suárez, Esther García-Planella, Orlando Garcia-Bosch, Marisa Iborra, Ana Gutierrez Casbas, Jesus Aparicio, Alonso Fernandez-Ni

PERFORMANCE OF SCREENING STRATEGIES FOR LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY OF GETECCU

Sabino Riestra, Javier Gisbert, Carlos Taxonera, Antonio López-Sanromán, Jesús Barrio, Maria Chaparro, Yamile Zabana, Daniel Carpio López, Montserrat Rivero, Ruth De Francisco, María Esteve, Pilar Nos, Santiago García López, Miriam Mañosa, José Lázaro Pérez-Calle, Jordi Guardiola, Fernando Muñoz, María Dolores Martín-Arran

REAL WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN CROHN’S DISEASE WHEN USED AS A FIRST BIOLOGIC OR AFTER FAILURE OF ONE PREVIOUS ANTI-TNF (EVOLVE-IB STUDY)

Fernando Muñoz, Cristina Rodriguez, Javier Pérez Gisbert, Claudia Herrera de Guise, Isabel Vera Mendoza, Ana Gutierrez Casbas, María Dolores Martín-Arranz, Pilar Martínez-Montiel, Vanesa Royo, Patricia Suárez, Esther García-Planella, Orlando Garcia-Bosch, Marisa Iborra, Jesus Aparicio, Ignacio Tagarro, Alonso Fernandez-Nista

Item 1 - 10 / 22
1
2 3